Paradigm shift in the pathomechanisms and treatment of inclusion body myositis: at the crossroads of cell-autonomous muscle degeneration and immune activation.

Suzuki N, Izumi R, Ikeda K

Open source

DOI
10.1097/wco.0000000000001511
Published
2026 Oct 1
Container
Current opinion in neurology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/wco.0000000000001511,
  title = {Paradigm shift in the pathomechanisms and treatment of inclusion body myositis: at the crossroads of cell-autonomous muscle degeneration and immune activation.},
  author = {Suzuki N and Izumi R and Ikeda K},
  year = {2026},
  journal = {Current opinion in neurology},
  doi = {10.1097/wco.0000000000001511},
  url = {https://doi.org/10.1097/wco.0000000000001511}
}

RIS

TY  - JOUR
TI  - Paradigm shift in the pathomechanisms and treatment of inclusion body myositis: at the crossroads of cell-autonomous muscle degeneration and immune activation.
AU  - Suzuki N
AU  - Izumi R
AU  - Ikeda K
PY  - 2026
JO  - Current opinion in neurology
DO  - 10.1097/wco.0000000000001511
UR  - https://doi.org/10.1097/wco.0000000000001511
ER  - 

APA

N, S., R, I., & K, I. (2026). Paradigm shift in the pathomechanisms and treatment of inclusion body myositis: at the crossroads of cell-autonomous muscle degeneration and immune activation.. Current opinion in neurology. https://doi.org/10.1097/wco.0000000000001511

Source records